Stock Track | ESAB Corporation Soars 5.12% Intraday on Q2 Sales Beat and Raised 2026 Guidance

Stock Track08-06

ESAB Corporation shares surged 5.12% intraday on Thursday following the release of its second-quarter 2026 earnings, which showcased strong sales performance and an upgraded full-year outlook.

The industrial compounder reported Q2 sales of $808 million, comfortably surpassing the consensus estimate of $758 million. Core adjusted EBITDA rose 8% to $150 million, driven by organic growth in North America and Asia, alongside resilient performance in Europe. Despite a slight miss on adjusted earnings per share—$1.33 versus the expected $1.38—investors focused on the company’s enhanced guidance and the ahead-of-schedule closing of the Eddyfi acquisition.

ESAB raised its full-year 2026 core net sales growth forecast to 11%–14%, up from a prior range of 6%–9%, and lifted its core adjusted EBITDA forecast to $615–$625 million. Management expressed confidence in mitigating transitory cost inflation and reaffirmed its commitment to long-term financial targets, further buoying market sentiment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment